eli lilly trials retatrutide phase 3 trial A new clinical trial from Eli Lilly and Company suggests Eli Lilly's Weight Loss Superdrug
Description
LNT, lentinan (-D-glucan from Lentinula edodes )
In clinical studies, participants experienced progressive weight loss throughout treatment, with results continuing to improve over several months
Nichols, T
Its very hard to fight biologyand we have to change how we think about that.
As we shared in our Q1 earnings date, this solution continues to perform as expected and is projected to generate over $100 million in revenue by 2025
